Stock Code: 300149 Stock Abbreviation: Ruizhi Pharmaceutical Announcement No.: 2026-19
Ruizhi Pharmaceutical Technology Co., Ltd.
Announcement on Confirmation of Directors' and Senior Management's 2025 Remuneration and 2026 Remuneration Plan
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false records, misleading statements, or major omissions.
Ruizhi Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") held the 16th meeting of the Sixth Board of Directors on April 27, 2026, and deliberated on the "Proposal on Confirmation of Directors' and Senior Management's 2025 Remuneration and 2026 Remuneration Plan." This proposal involves the remuneration of all directors. Based on the principle of prudence, all directors abstained from voting, and this proposal was directly submitted to the Company's 2025 Annual Shareholders' Meeting for deliberation. The specific situation is hereby announced as follows:
I. Confirmation of Directors' and Senior Management's 2025 Remuneration
In 2025, non-independent directors and senior management personnel employed by the Company received remuneration according to the company's relevant remuneration assessment system based on their specific positions held in the Company. Independent directors' remuneration was paid monthly in the form of allowances. After calculation, the remuneration of the Company's directors and senior management in 2025 is as follows: